Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response☆ | Zendy

N. Pourel | Zendy; Nicola Santelmo | Zendy; Nidal Naafa | Zendy; Antoine Serre | Zendy; Werner Hilgers | Zendy; Laurent Mineur | Zendy; Nicolas Molinari | Zendy; F Reboul | Zendy

Open Access

Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response☆

Author(s) -

N. Pourel,

Nicola Santelmo,

Nidal Naafa,

Antoine Serre,

Werner Hilgers,

Laurent Mineur,

Nicolas Molinari,

F Reboul

Publication year - 2008

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2008.01.063

Subject(s) - etoposide , medicine , sulcus , radiation therapy , pathological , stage (stratigraphy) , cisplatin , cancer , radiology , oncology , surgery , chemotherapy , pathology , biology , paleontology

Optimal preoperative treatment of stage IIB (Pancoast)/III non-small cell lung cancer (NSCLC) remains undetermined and a subject of controversy. The goal of our study is to confirm feasibility and pathological response rates after induction chemoradiation (CRT) in our community-based treatment center.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research